Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The extracellular matrix (ECM) and membrane proteolysis play a key role in structural and functional synaptic plasticity associated with development and learning. A growing body of evidence underscores the multifaceted role of members of the metzincin superfamily, including metalloproteinases (MMPs), A Disintegrin and Metalloproteinases (ADAMs), A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTSs) and astacins in physiological and pathological processes in the central nervous system (CNS). The expression and activity of metzincins are strictly controlled at different levels (e.g., through the regulation of translation, limited activation in the extracellular space, the binding of endogenous inhibitors and interactions with other proteins). Thus, unsurprising is that the dysregulation of proteolytic activity, especially the greater expression and activation of metzincins, is associated with neurodegenerative disorders that are considered synaptopathies, especially Alzheimer's disease (AD). We review current knowledge of the functions of metzincins in the development of AD, mainly the proteolytic processing of amyloid precursor protein, the degradation of amyloid β (Aβ) peptide and several pathways for Aβ clearance across brain barriers (i.e., blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB)) that contain specific receptors that mediate the uptake of Aβ peptide. Controlling the proteolytic activity of metzincins in Aβ-induced pathological changes in AD patients' brains may be a promising therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · cited 3×
“The crucial factor in this process may be the segregation of APP and respective secretases into lipid rafts Frontiers in Cellular Neuroscience | www.frontiersin.org 10 June 2017 | Volume 11 | Article 178 or endocytic vesicles (Ehehalt et al., 2003; O’Brien and Wong, 2011).”
BackgroundClearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 2×
“Uncontrolled excess or deficiency of the extracellular or membrane proteolysis is often implicated in the etiology of many neurodegenerative disorders that are considered synaptopathies, such as Alzheimer’s disease (AD) and epilepsy (Palop and Mucke, 2010; Bronisz and Kurkowska-Jastrzebska, 2016).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“Although the precise mechanisms by which Aβ peptide induces LTD are not fully understood, but it is known that it depends on AMPA and NMDA receptor internalization and the disappearance of dendritic spines (Snyder et al., 2005; D’Amelio et al., 2011; Reinders et al., 2016).”
BackgroundShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“Several studies have utilized specific antibodies or antagonists that block the ligand binding site (Shibata et al., 2000; Yamada et al., 2008).”
BackgroundApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
Application of a translational profiling approach for the comparative analysis of CNS cell types
Doyle, J. P., Dougherty, J. D., Heiman, M., Schmidt, E. F., Stevens, T. R., Ma, G., Bupp, S., Shrestha, P., Shah, R. D., Doughty, M. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.029 · Cited by 912
Cell type- and brain region-resolved mouse brain proteome
Sharma, K., Schmitt, S., Bergner, C. G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., Kongi, K., Cantuti, L., Hanisch, U.-K., Philips, M.-A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4160 · Cited by 785
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · cited 1×
“Interestingly, patients with the inherited form of AD often suffer from symptoms of epilepsy because of excess glutamate in the synapse in the hippocampus and entorhinal cortex (Palop and Mucke, 2009), further confirming the notion that AD is a synaptopathy.”
BackgroundKuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621 · cited 1×
“Among the ADAM family, ADAM10 (but not ADAM9 or ADAM17) has particularly strong constitutive α-secretase activity in vivo (Kuhn et al., 2010).”
BackgroundHuman amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572 · cited 2×
“Although the precise mechanisms by which Aβ peptide induces LTD are not fully understood, but it is known that it depends on AMPA and NMDA receptor internalization and the disappearance of dendritic spines (Snyder et al., 2005; D’Amelio et al., 2011; Reinders et al., 2016).”
BackgroundMatrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477 · cited 21×
“(2) Aβ1–42 interacts with receptor for advanced glycation end products (RAGE) in the BBB, resulting in the expression of MMPs, dysregulation of TJs and breakdown of the BBB (red; Kook et al., 2012).”
BackgroundInfluentialBilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., & Ethell, I. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061796 · Cited by 465 · cited 1×
“Whereas, the extended application of exogenous recombinant active MMP-9 leads to the elongation of dendritic spines (Bilousova et al., 2009; Michaluk et al., 2011).”
BackgroundCasting a Wide Net: Role of Perineuronal Nets in Neural Plasticity
Sorg, B. A., Berretta, S., Blacktop, J. M., Fawcett, J. W., Kitagawa, H., Kwok, J. C. F., & Miquel, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2351-16.2016 · Cited by 454
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398 · cited 3×
“Additionally, a recent study found that MT5-MMP and soluble MMPs contributed to η-secretase activity (Willem et al., 2015).”
BackgroundInfluentialRing, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A., Herms, J., Buchholz, C., Eckman, C. B., Korte, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1026-07.2007 · Cited by 390 · cited 2×
“For example, ADAM-10 cleaves neuronal APP and releases a soluble domain called sAPPα that affects the induction of LTP and learning (Ring et al., 2007).”
BackgroundMatrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism
Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2085-06.2006 · Cited by 381
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380 · cited 6×
“However, other MT1-MMP cleavage sites were identified in the region between V12 and L17 that are similar to the sequences that are cleaved by IDE (e.g., H14-Q16, Q16-K16; Yan et al., 2006; Liao and Van Nostrand, 2010).”
BackgroundInfluentialBackstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · cited 1×
“…Aβ have been identified in vitro: MMP2 (Roher et al., 1994), plasmin (Ledesma et al., 2000), endothelin-converting enzyme (ECE; Eckman et al., 2001), insulin-degrading enzyme (IDE; Kurochkin and Goto, 1994), neprilysin (NEP; Howell et al., 1995) and MMP-9 (Backstrom et al., 1996; Yan et al., 2006).”
BackgroundWang, X.-B., Bozdagi, O., Nikitczuk, J. S., Zhai, Z. W., Zhou, Q., & Huntley, G. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807248105 · Cited by 316
Important role of matrix metalloproteinase 9 in epileptogenesis
Wilczynski, G. M., Konopacki, F. A., Wilczek, E., Lasiecka, Z., Gorlewicz, A., Michaluk, P., Wawrzyniak, M., Malinowska, M., Okulski, P., Kolodziej, L. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708213 · Cited by 292 · cited 1×
“Moreover, the prolonged neuronal overexpression of MMP-9 in rats negatively affects LTP induction in the hippocampus (Wiera et al., 2013, 2015; Magnowska et al., 2016) and increases the severity of kainate-induced epilepsy (Wilczynski et al., 2008).”
BackgroundInterleukin-1β Induces Blood–Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes
Wang, Y., Jin, S., Sonobe, Y., Cheng, Y., Horiuchi, H., Parajuli, B., Kawanokuchi, J., Mizuno, T., Takeuchi, H., & Suzumura, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110024 · Cited by 286
Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., & Winkler, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07002.x · Cited by 261
Very long-term memories may be stored in the pattern of holes in the perineuronal net
Tsien, R. Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310158110 · Cited by 244
Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology
Michaluk, P., Wawrzyniak, M., Alot, P., Szczot, M., Wyrembek, P., Mercik, K., Medvedev, N., Wilczek, E., De Roo, M., Zuschratter, W., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.090852 · Cited by 214 · cited 2×
“Whereas, the extended application of exogenous recombinant active MMP-9 leads to the elongation of dendritic spines (Bilousova et al., 2009; Michaluk et al., 2011).”
BackgroundSelf-citationYoung-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C., & Selkoe, D. J. (2008) · Neural Development · doi:10.1186/1749-8104-3-15 · Cited by 210
Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201 · cited 2×
“Latent proMMP-9 is locally translated in dendrites (Dziembowska et al., 2012) in a process that depends on fragile X mental retardation 1 protein (Janusz et al., 2013; Sidhu et al., 2014), eukaryotic initiation factor 4E (Gkogkas et al., 2014) and miR-132 (Jasínska et al., 2016).”
BackgroundActivity-dependent exocytosis of lysosomes regulates the structural plasticity of dendritic spines
Padamsey, Z., McGuinness, L., Bardo, S. J., Reinhart, M., Tong, R., Hedegaard, A., Hart, M. L., & Emptage, N. J. (2017) · Neuron · doi:10.1016/j.neuron.2016.11.013 · Cited by 186
Bozdagi, O., Nagy, V., Kwei, K. T., & Huntley, G. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00202.2007 · Cited by 182
Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons
Mardinly, A. R., Spiegel, I., Patrizi, A., Centofante, E., Bazinet, J. E., Tzeng, C. P., Mandel-Brehm, C., Harmin, D. A., Adesnik, H., Fagiolini, M., et al. (2016) · Nature · doi:10.1038/nature17187 · Cited by 176 · cited 1×
“Interestingly, the activity-dependent expression of ADAMTS-1 mRNA was found exclusively in somatostatin positive interneurons (Mardinly et al., 2016).”
BackgroundHigh MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36023 · Cited by 161 · cited 1×
“Among metzincins, MMP-9 is by far the most widely studied protease in the context of synaptic plasticity, learning, and memory (Dziembowska et al., 2013; Kaczmarek, 2016).”
BackgroundSidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · cited 2×
“, 2012) in a process that depends on fragile X mental retardation 1 protein (Janusz et al., 2013; Sidhu et al., 2014), eukaryotic initiation factor 4E (Gkogkas et al.”
BackgroundQosa, H., Abuasal, B. S., Romero, I. A., Weksler, B., Couraud, P.-O., Keller, J. N., & Kaddoumi, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.023 · Cited by 146 · cited 1×
“Notably, there are differences in the rate of Aβ clearance between mice and humans, with five-fold higher clearance in the mouse brain (Qosa et al., 2014).”
Backgroundvan der Kooij, M. A., Fantin, M., Rejmak, E., Grosse, J., Zanoletti, O., Fournier, C., Ganguly, K., Kalita, K., Kaczmarek, L., & Sandi, C. (2014) · Nature Communications · doi:10.1038/ncomms5995 · Cited by 140 · cited 2×
“The best documented neuronal substrates of MMP-9 are neuroligin-1 (Peixoto et al., 2012), nectin-3 (van der Kooij et al., 2014), pro-BDNF (Mizoguchi et al., 2011a), β-dystroglycan (Michaluk et al., 2007; Ganguly et al., 2013; Knapska et al., 2013) and intercellular adhesion molecule 5 (ICAM-5;…”
BackgroundSelective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain
Yoshiyama, Y., Asahina, M., & Hattori, T. (2000) · Acta Neuropathologica · doi:10.1007/pl00007428 · Cited by 128 · cited 2×
“MMP-9 was detected in the cytoplasm of neurons and co-localized with neurofibrillary tangles and Aβ plaques (Yoshiyama et al., 2000; Yin et al., 2006; Mizoguchi et al., 2011b).”
BackgroundCho, R. W., Park, J. M., Wolff, S. B. E., Xu, D., Hopf, C., Kim, J.-A., Reddy, R. C., Petralia, R. S., Perin, M. S., Linden, D. J., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.010 · Cited by 125
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
Choi, D.-H., Kim, Y.-J., Kim, Y.-G., Joh, T. H., Beal, M. F., & Kim, Y.-S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222430 · Cited by 123 · cited 2×
“…numerous studies have identified several intracellular and nuclear substrates of neuronal MMP-3, MT1-MMP and MMP-9 (Cauwe and Opdenakker, 2010; Choi et al., 2011; Wiera et al., 2012), thus making their brain function more complex and the effective targeting of specific types of MMPs more…”
BackgroundYuan, W., Matthews, R. T., Sandy, J. D., & Gottschall, P. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00347-0 · Cited by 109 · cited 1×
“At least two proteoglycanases, ADAMTS-1 and ADAMTS-4, are able to cleave the chondroitin sulfate proteoglycan brevican, releasing a characteristic truncated fragment that was found in the hippocampus (Nakamura et al., 2000; Yuan et al., 2002).”
BackgroundNagy, V., Bozdagi, O., & Huntley, G. W. (2007) · Learning & Memory · doi:10.1101/lm.678307 · Cited by 107 · cited 2×
“, 2006), inhibitory avoidance learning (Nagy et al., 2007) and appetitive amygdaladependent learning (Knapska et al.”
BackgroundBilousova, T. V., Rusakov, D. A., Ethell, D. W., & Ethell, I. M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03701.x · Cited by 98 · cited 2×
“, 2007), resulting in the elongation of dendritic spines (Bilousova et al., 2006) and ectodomain cleavage of the NMDA receptor (Szklarczyk et al.”
BackgroundSzepesi, Z., Hosy, E., Ruszczycki, B., Bijata, M., Pyskaty, M., Bikbaev, A., Heine, M., Choquet, D., Kaczmarek, L., & Wlodarczyk, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098274 · Cited by 83 · cited 2×
“, 2017), the structural plasticity of dendritic spines (Szepesi et al., 2014), ocular dominance plasticity (Spolidoro et al.”
BackgroundSpolidoro, M., Putignano, E., Munafò, C., Maffei, L., & Pizzorusso, T. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr158 · Cited by 58
Wiera, G., Wozniak, G., Bajor, M., Kaczmarek, L., & Mozrzymas, J. W. (2013) · Hippocampus · doi:10.1002/hipo.22112 · Cited by 57 · cited 2×
“Gene knockout or inhibition of MMP-9 in mice blocks the maintenance of LTP at different synapses in the hippocampus (Nagy et al., 2006; Wiera et al., 2013; Wójtowicz and Mozrzymas, 2014), amygdala (Gorkiewicz et al., 2015), and cerebral cortex (Okulski et al., 2007; Lebida and Mozrzymas, 2016).”
Background
Cited by
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B. (2020) · Cells · doi:10.3390/cells9051313 · Cited by 324
Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges
Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94
Extracellular Metalloproteinases in the Plasticity of Excitatory and Inhibitory Synapses
Wiera, G., & Mozrzymas, J. W. (2021) · Cells · doi:10.3390/cells10082055 · Cited by 36
“In addition, an essential role of extracellular proteases in pathological plasticity that is related, for example, to addiction [5], epilepsy [9], or Alzheimer’s disease [10] has recently been reviewed.”
BackgroundSelf-citationWiera, G., Brzdąk, P., Lech, A. M., Lebida, K., Jabłońska, J., Gmerek, P., & Mozrzymas, J. W. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1458-21.2022 · Cited by 25
Self-citationLlorente, P., Martins, S., Sastre, I., Aldudo, J., Recuero, M., Adjaye, J., & Bullido, M. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5917187 · Cited by 10
Metadata
- Authors
- Brzdak, P., Nowak, D., Wiera, G., & Mozrzymas, J. W.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-06-30
- Volume
- 11
- Pages
- 178-178
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2728505972
- Cited by
- 21
- References
- 46
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.